Aarti Pharmalabs Ltd vs Ang Lifesciences India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 696.4 as of 18 May 14:30 . The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 0 on March 2021 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of ANG Lifesciences India Ltd changed from 6 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2023 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of ANG Lifesciences India Ltd changed from ₹ 243.2 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Aarti Pharmalabs Ltd for the Dec '25 is ₹ 436.83 crore as compare to the Sep '25 revenue of ₹ 418.39 crore. This represent the growth of 4.41% The revenue of ANG Lifesciences India Ltd for the Dec '25 is ₹ 18.89 crore as compare to the Sep '25 revenue of ₹ 26.18 crore. This represent the decline of -27.85% The ebitda of Aarti Pharmalabs Ltd for the Dec '25 is ₹ 104.07 crore as compare to the Sep '25 ebitda of ₹ 74.13 crore. This represent the growth of 40.39% The ebitda of ANG Lifesciences India Ltd for the Dec '25 is ₹ -2.53 crore as compare to the Sep '25 ebitda of ₹ 0.2 crore. This represent the decline of -1365% The net profit of Aarti Pharmalabs Ltd changed from ₹ 55.45 crore to ₹ 47.96 crore over 7 quarters. This represents a CAGR of -7.96% The net profit of ANG Lifesciences India Ltd changed from ₹ -3.07 crore to ₹ -4.75 crore over 7 quarters. This represents a CAGR of 28.33% The Dividend Payout of Aarti Pharmalabs Ltd changed from 10.55 % on March 2023 to 17.61 % on March 2025 . This represents a CAGR of 18.62% over 3 yearsThe Dividend Payout of ANG Lifesciences India Ltd changed from 2.61 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019.
The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022.
Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.

About ANG Lifesciences India Ltd

ANG Lifesciences India Limited was originally incorporated as a Private Limited Company with the name 'ANG Lifesciences India Private Limited' on June 14, 2006.
On conversion into Public Limited Company, the name was changed to ANG Lifesciences India Limited on March 02, 2010.
The Company further converted into Private Limited Company and the name of the Company was changed to 'ANG Lifesciences India Private Limited' on September 22, 2010.
Subsequently, on conversion into Public Limited Company, the name again changed to 'ANG Lifesciences India Limited' on May 18, 2016. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulation in the form of Sterile Dry Powder Injection Vials.
In 2008-09, the Company started its commercial production.

FAQs for the comparison of Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd

Which company has a larger market capitalization, Aarti Pharmalabs Ltd or ANG Lifesciences India Ltd?

Market cap of Aarti Pharmalabs Ltd is 6,480 Cr while Market cap of ANG Lifesciences India Ltd is 35 Cr

What are the key factors driving the stock performance of Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd?

The stock performance of Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd?

As of May 18, 2026, the Aarti Pharmalabs Ltd stock price is INR ₹714.8. On the other hand, ANG Lifesciences India Ltd stock price is INR ₹26.88.

How do dividend payouts of Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd compare?

To compare the dividend payouts of Aarti Pharmalabs Ltd and ANG Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.